So tell me about MED-C.
Dane Dickson would like to change the U.S. system for validation and coverage of molecular tests, thereby opening the road to development of complex tests and comprehensive genomic assays.
The cancer field is filled with advocates—advocates for research into specific forms of malignancy, advocates for access to care for patients with limited resources, advocates for pediatric cancers—you name it. Many of these people are motivated, passionate, determined, and successful in moving their specific agendas forward in the interests of patients, clinicians, researchers, and others.
The membership of the National Academy of Sciences voted April 28 at its 152ndannual meeting to change the name of the Institute of Medicine to the National Academy of Medicine, effectiveJuly 1.
The House Committee on Energy and Commerce published the second “discussion draft” for a comprehensive bipartisan initiative aimed at streamlining development of drugs and medical devices.
NCI surgeon Richard Sherry tried unsuccessfully to refocus FDA's approval question.
José Baselga was inaugurated as president of the American Association for Cancer Research for 2015-2016, during the association's annual meeting in Philadelphia.
